Potential of in vitro microelectrode arrays in Alzheimer''''s disease researchOA
Alzheimer''s disease (AD) is a progressive neurodegenerative disorder and is the most prominent cause of dementia.In 2019,over 57.4million people were living with AD and other dementia subtypes,a number which is expected to increase to over 152.8 million in the next 25years.This ever-increasing burden has resulted in AD and other neurodegenerative diseases rising to one of the top 10 causes of death globally (O''Connell et al.,2024).
Aoife O’Connell;Andrea Kwakowsky
Pharmacology and Therapeutics,School of Medicine,Galway Neuroscience Center,University of Galway,Galway,IrelandPharmacology and Therapeutics,School of Medicine,Galway Neuroscience Center,University of Galway,Galway,Ireland
医药卫生
neurodegenerative diseasesvitro microelectrode arraysglobal burdenresearchalzheimers diseaseneurodegenerative disorderdementiaAlzheimers disease
《Neural Regeneration Research》 2026 (5)
P.1993-1994,2
评论